Bastide Le Confort Médical (EPA:BLC) Hasn't Managed To Accelerate Its Returns

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. That's why when we briefly looked at Bastide Le Confort Médical's (EPA:BLC) ROCE trend, we were pretty happy with what we saw.

Advertisement

Understanding Return On Capital Employed (ROCE)

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Bastide Le Confort Médical, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.10 = €44m ÷ (€647m - €216m) (Based on the trailing twelve months to June 2024).

So, Bastide Le Confort Médical has an ROCE of 10%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Healthcare industry average of 9.1%.

See our latest analysis for Bastide Le Confort Médical

roce
ENXTPA:BLC Return on Capital Employed February 17th 2025

In the above chart we have measured Bastide Le Confort Médical's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Bastide Le Confort Médical .

What Can We Tell From Bastide Le Confort Médical's ROCE Trend?

The trend of ROCE doesn't stand out much, but returns on a whole are decent. Over the past five years, ROCE has remained relatively flat at around 10% and the business has deployed 60% more capital into its operations. Since 10% is a moderate ROCE though, it's good to see a business can continue to reinvest at these decent rates of return. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.

The Bottom Line

The main thing to remember is that Bastide Le Confort Médical has proven its ability to continually reinvest at respectable rates of return. However, despite the favorable fundamentals, the stock has fallen 36% over the last five years, so there might be an opportunity here for astute investors. That's why we think it'd be worthwhile to look further into this stock given the fundamentals are appealing.

If you'd like to know more about Bastide Le Confort Médical, we've spotted 3 warning signs, and 1 of them is concerning.

While Bastide Le Confort Médical isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Valuation is complex, but we're here to simplify it.

Discover if Bastide Le Confort Médical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ENXTPA:BLC

Bastide Le Confort Médical

Engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy.

Moderate growth potential with low risk.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0775.1% undervalued
110 users have followed this narrative
1 users have commented on this narrative
19 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9819.4% undervalued
34 users have followed this narrative
0 users have commented on this narrative
29 users have liked this narrative
KO
CSL logo
Kouj on CSL ·

CSL: The Dip Is the Opportunity

Fair Value:AU$1559.0% undervalued
13 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
GA
DHT logo
GavrielH on DHT Holdings ·

DHT Holdings, inc: Strait of Hormuz Risk Amidst US-Israel vs Iran Tensions Spikes VLCC Rates.

Fair Value:US$3650.4% undervalued
12 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

JE
TEAM logo
JeffreyZhu on Atlassian ·

Atlassian will shine with 14.32% projected revenue growth

Fair Value:US$83.419.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SH
ASML logo
shravani on ASML Holding ·

ASML: The Hidden Backbone of the Global AI and Semiconductor Revolution.

Fair Value:€1.52k21.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
CEINSYS logo
max_profit on Ceinsys Tech ·

Ceinsys Tech Fair value at rs 1643

Fair Value:₹1.64k40.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.5% undervalued
52 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59632.1% undervalued
1306 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.5% undervalued
1102 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative